More than 40 drugs have been demonstrated to interact with grapefruit juice, primarily drugs that are first-pass metabolized. Join host Dr. Larry Kaskel and guest Dr. David Baily to discuss the serious nature of potential grapefruit juice/drug interactions and how best to communicate the required cautions to patients. Then learn of current research working to identify other natural foods that may modulate the absorbtion of drugs.
Grapefruit Juice and Drug Metabolism
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Recommended
Details
Presenters
Overview
More than 40 drugs have been demonstrated to interact with grapefruit juice, primarily drugs that are first-pass metabolized. Join host Dr. Larry Kaskel and guest Dr. David Baily to discuss the serious nature of potential grapefruit juice/drug interactions and how best to communicate the required cautions to patients. Then learn of current research working to identify other natural foods that may modulate the absorbtion of drugs.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
MinuteCE®
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
1.00 credits
<p>I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis</p>
MinuteCE®
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
1.00 credits
<p><span data-contrast="none" xml:lang="EN-US">Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli</span> </p>
MinuteCE®
Maximizing Adherence and Persistence via Patient Engagement
1.25 credits
<p>Maximizing Adherence and Persistence via Patient Engagement</p>
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 credits
<p>Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy</p>
CME/CE
Impact of Barostim on Heart Failure Hospitalization
<p>Impact of Barostim on Heart Failure Hospitalization</p>
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
<p>Navigating Myasthenia Gravis in Adolescents and Young Adults</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?